Introduction
Chromosomal translocations are frequently present in human leukemia cells and are involved in the development of leukemias by forced activation of oncogenes or the formation of novel fusion genes. 1, 2 The t(8;21)(q22;q22) translocation is one of the most common chromosomal translocations occurring in acute myelogenous leukemia (AML) cells. Patients with this translocation usually have a marrow cytology that corresponds to the M2 subtype of the FAB classification. 3 Characteristically, the blasts often contain prominent Auer rods and homogenous salmon-colored granules, and show strong myeloperoxidase positivity and cytoplasmic vacuolization. 4 In addition, abnormal granulocytic maturation is usually evident. Promyelocytes often show intense azurophil granulation. Nucleoli persistently exist at the metamyelocyte stage. Nuclei fail to segment normally, and often demonstrate the pseudo Pelger-Hü et anomaly. In the cytoplasm, there is disordered maturation, which is marked by the presence of Auer rods and the failure of specific granules to form at the myelocyte stage. 5 The t(8;21) translocation was shown to involve the AML1 (RUNX1) gene 6 on chromosome 21 and the MTG8 (ETO) gene on chromosome 8, generating the AML1-MTG8 fusion tran-scription factor. [7] [8] [9] [10] This fusion protein consists of the N-terminal portion of AML1 fused in frame to a nearly full-length MTG8 protein. Native AML1 forms a heterodimeric complex with CBF␤ (PEBP2␤) and regulates the transcription of target genes by binding to the DNA sequence TGT/cGGT. [11] [12] [13] The DNA-binding activity of AML1 is mediated through an N-terminal 128-amino acid region, which shares extensive homology with the Drosophila pair-rule segmentation protein, Runt, and is referred to as the Runt domain. [14] [15] [16] Its affinity for DNA is augmented by heterodimerization with a non-DNAbinding subunit, CBF␤.
11,17 AML1-mediated transcriptional activation also requires a C-terminal transactivation domain, which interacts with the multifunctional transcriptional coactivators, p300 and CBP. 18 AML1 is a critical regulator of a number of hematopoietic cell-specific genes including those encoding granule proteins (myeloperoxidase, neutrophil elastase 19 and NP-3), 20 cytokines (interleukin-3 (IL-3) 21 and granulocyte-macrophage colony-stimulating factor (GM-CSF)), 22, 23 and cell surface receptors (macrophage colony-stimulating factor (M-CSF) receptor 24 and T cell antigen receptors). 13, 25, 26 Targeted disruption of AML1 and CBF␤ has demonstrated that both are essential for definitive hematopoiesis of all lineages in mouse fetal liver. [27] [28] [29] [30] The MTG8 protein contains two putative zinc fingers and several proline-rich regions, 9, 31 and interacts with the nuclear receptor corepressor (N-CoR)/mSin3/histone deacetylase (HDAC) complex, [32] [33] [34] suggesting that MTG8 functions as a transcriptional corepressor.
The AML1-MTG8 fusion protein contains the DNA-binding domain (Runt domain) of AML1 and the portion of MTG8 that interacts with the N-CoR/mSin3/HDAC corepressor complex, but lacks the C-terminal region of AML1 that interacts with the p300 and CBP histone acetyltransferase coactivators. Therefore, AML1-MTG8 most likely recruits histone deacetylase to the promoters of AML1-responsive target genes, probably resulting in the deacetylation of histones in these regions and transcriptional repression. Supporting this idea are the findings that AML1-MTG8 dominantly inhibits AML1-dependent transactivation of the TCR␤ enhancer 35 and the GM-CSF promoter. 22 In AML1-MTG8 knock-in mice, definitive hematopoiesis from the normal fetal liver is completely absent. 36, 37 This result is similar to that obtained in Aml1 knockout mice, and indicates that AML1-MTG8 can also block normal AML1 function in vivo through a dominant-negative mechanism. However, in contrast to Aml1 knockout mice, AML1-MTG8 knock-in mice were found to contain dysplastic multilineage hematopoietic progenitors within their fetal livers, which had an abnormally high self-renewal capacity in vitro. 37 This observation suggested that AML1-MTG8 had functions other than just blocking normal AML1 function. To understand the functions of AML1-MTG8 and its role in the leukemogenic process, we felt it was essential to identify the genes with altered expression caused by AML1-MTG8.
Ectopic expression of AML1-MTG8 in a murine myeloid progenitor cell line, L-G, blocks differentiation into mature neutrophils, and induces granulocyte colony-stimulating factor (G-CSF)-dependent cell proliferation. 38 We have been attempting to identify genes under the downstream control of AML1-MTG8 by comparing gene expression between control L-G cells and those expressing AML1-MTG8. We previously used a differential display method, and identified 24 downstream genes whose expression was affected by AML1-MTG8. 39 One of the genes affected, Tis11b, was suggested to be partially responsible for leukemogenesis. 39 In addition, the expression of genes encoding G-CSF receptor, myeloperoxidase, and C/EBP⑀ was also affected by AML1-MTG8 in this cell system. 40 In the present study, we compared the expression of approximately 6500 genes by using oligonucleotide microarrays, and identified 32 candidate genes that were under the downstream control of AML1-MTG8. The expression of nine of these genes was known to be affected by AML1-MTG8. Northern hybridization confirmed the results of the microarray analyses for all 19 genes that were examined, which included several markers for myeloid cell differentiation. The genes of azurophil granule proteins were up-regulated, suggesting that AML1-MTG8 could induce the partial differentiation of myeloid progenitor cells. These features correlate well with the characteristics of the leukemic cells carrying the t(8;21) translocation.
Materials and methods

Cells and retroviruses
Control and AML1-MTG8-expressing L-G cells were constructed by infection of LNSX and LNSX-HA-AML1-MTG8 retroviruses as described previously. 39 To express AML1b excessively in AML1-MTG8-expressing cells, L-G cells were successively infected with LXSH and LXSH-HA-AML1-MTG8 retroviruses and then with LNSX and LNSX-HA-AML1b retroviruses, as described previously. 40 The infected cells were antibiotics-selected and cultured in RPMI1640 medium supplemented with 10% fetal calf serum, 0.1 ng/ml recombinant mouse IL-3 (a generous gift from Kirin Brewery, Tokyo, Japan), and 50 M ␤-mercaptoethanol, and used for RNA preparation as a mixture of infectants. Expression of AML1-MTG8 and AML1b proteins was confirmed by Western blotting analyses using anti-HA antibody as described previously. 39, 40 Prior to culture of L-G cells with G-CSF, the cells maintained in the presence of IL-3 were washed twice with phosphate-buffered saline (PBS) and incubated in medium containing 10 ng/ml recombinant human G-CSF (a generous gift from Chugai Pharmaceutical, Tokyo, Japan) in place of IL-3.
Preparation of target cRNA for oligonucleotide microarray analysis
Poly(A) RNA was isolated from control and AML1-MTG8-expressing L-G cells that had been cultured in the presence of IL-3, by using a MACS mRNA isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. First-strand cDNA was synthesized by reverse transcription of 2 g of poly(A) RNA with 100 pmol of T7-(dT) 24 primer (5Ј-GGCCAGTGAATTGTAATAC-GACTCACTATAGGGAGGCGG-(T) 24 
Oligonucleotide microarray analysis
We used a commercial oligonucleotide microarray set, which consisted of four microarrays, with the capacity to assess approximately 6500 murine genes consisting of known genes and expressed sequence tags (ESTs) (GeneChip Mu6500 set) (Affymetrix, Santa Clara, CA, USA). Target hybridization, washing, staining, and scanning were carried out according to the manufacturer's instructions. Briefly, 10 g of the biotinlabeled and fragmented cRNA was hybridized to each of four microarrays in 200 l of 1 × MES hybridization buffer (100 mM MES/Na-MES (pH 6.6), 890 mM NaCl, 20 mM EDTA, 0.01% Tween 20) containing 0.1 mg/ml of herring sperm DNA (Promega, Madison, WI, USA) and 0.5 mg/ml of acetylated bovine serum albumin (Gibco-BRL) at 45°C for 16 h with rotation. Subsequently, the microarrays were washed with non-stringent wash buffer (60 mM Na 2 HPO 4 /NaH 2 PO 4 (pH 7.4), 894 mM NaCl, 6 mM EDTA, 0.01% Tween 20, 0.005% Antifoam (Sigma, St Louis, MO, USA)) at 25°C and then with stringent wash buffer (100 mM MES/Na-MES (pH 6.6), 26 mM NaCl, 0.01% Tween 20) at 50°C, stained with streptavidin phycoerythrin (Molecular Probes, Eugene, OR, USA), and scanned with a GeneArray Scanner (Hewlett-Packard, Santa Clara, CA, USA). Hybridization signals were analyzed by GeneChip 3.3 software (Affymetrix). To determine which genes were significantly affected by AML1-MTG8, the following criteria were used. The transcript of the gene had to be 'present' in either control or AML1-MTG8-expressing cells by absolute analysis of the software, which meant that it was expressed at levels higher than the detectable level. And, in both of two independent experiments, the expression of the gene had to be changed at least three-fold in cells expressing AML1-MTG8 compared to that in control cells, when calculated by comparison analysis of the software.
Northern hybridization analysis
The probe for Mpo (myeloperoxidase) has been described previously. 40 The following probes were generated by RT-PCR using total RNA from control or AML1-MTG8-expressing L-G cells:
Cybb (gp91phox) and Mmp9 (gelatinase B). The PCR primers were designed based on the published cDNA sequences (Table 1) . Total RNAs were isolated by the acid guanidinium thiocyanate/phenol/chloroform method 41 or by using RNeasy columns. Five micrograms of each sample of RNA were electrophoresed in a 1% agarose gel containing 2.2 M formaldehyde in 20 mM MOPS/NaOH (pH 7.0)/8 mM sodium acetate/1 mM EDTA, and transferred to Hybond-N membranes (Amersham Pharmacia Biotech). Hybridization was performed at 42°C for 20 h in 6 × SSC/10% dextran sulfate/1% SDS/1 × Denhardt's solution/50% formamide/0.1 mg/ml denatured salmon sperm DNA. The membranes were washed several times in 0.1 × SSC/0.1% SDS at 65°C, and the hybridized transcripts were detected with a BAS2000 image analyzer (Fuji Film, Tokyo, Japan). To confirm the amount of RNA loaded on to each lane, all membranes were subsequently hybridized with a human G3PDH (glyceraldehide-3-phosphate dehydrogenase) probe (BD Biosciences Clontech, Palo Alto, CA, USA).
Patient samples and semiquantitative RT-PCR analysis
Leukemic cell RNAs of two non-t(8;21) AML patients (P1 and P2) and three t(8;21) AML patients (P3, P4 and P5), who were diagnosed as the M2 subtype according to the FAB classification, were prepared from bone marrow cells (P1, P2 and P5) or peripheral blood mononuclear cells (P3 and P4). Control RNAs were from bone marrow cells of one patient with Ewing sarcoma (C1), two with idiopathic thrombocytopenic CACAGTAAGCATTCTGTGGG purpura (C2 and C3), and two with common acute lymphoblastic leukemia during complete remission (C4 and C5), which contained less than 5% blast cells and showed normal maturation of other marrow elements. Total RNA, isolated by the acid guanidinium thiocyanate/phenol/chloroform method, was reversely transcribed using oligo-dT primer with a SuperScript preamplification system (Gibco-BRL). Each singlestrand cDNA was appropriately diluted for subsequent PCR amplification by monitoring the ACTB (␤-actin) gene as a quantitative control. PCR amplification was carried out by 23 to 35 cycles of denaturation at 94°C for 20 s, annealing at 58 to 60°C for 40 s, and extension at 72°C for 1 min. PCR primers were designed based on the published cDNA sequences ( Table 2) .
Results
Identification of genes whose expression was altered by AML1-MTG8, using oligonucleotide microarrays
To investigate the role of AML1-MTG8 in leukemogenesis, we identified genes whose expression was altered by AML1-MTG8 in a murine myeloid progenitor cell line L-G. This was achieved by screening approximately 6500 known genes and ESTs using oligonucleotide microarrays. L-G cells require IL-3 for survival and proliferation, and undergo granulocytic differentiation in response to G-CSF. 42 Ectopic expression of AML1-MTG8 in L-G cells induces G-CSF-dependent cell proliferation and blocks differentiation into mature neutrophils. 38 cRNA was prepared from RNA isolated from control L-G cells and those expressing AML1-MTG8 grown in the presence of IL-3, and used as the hybridization probe for the microarrays (see Materials and methods). Experiments were duplicated by using independently prepared RNA samples. Genes whose expression was changed more than three-fold in both experiments were judged to be significantly affected by AML1-MTG8, and thus, under the downstream control of AML1-MTG8 (see Materials and methods). In screening approximately 6500 genes, a total of 32 genes were identified as being under the downstream control of AML1-MTG8. The accession number of the GenBank/EMBL/DDBJ database entry from which the oligonucleotide probe sequences were designed. b Fold changes were determined by averaging the data from two independent experiments. c
The origin of each EST was identified or presumed from the highest scoring sequence in a BLAST search of the GenBank/EMBL/DDBJ database. d AG, azurophil granule; SG, specific granule; GG, gelatinase granule. The accession number of the GenBank/EMBL/DDBJ database entry from which the oligonucleotide probe sequences were designed. b Fold changes were determined by averaging the data from two independent experiments. The origin of each EST was identified or presumed from the highest scoring sequence in a BLAST search of the GenBank/EMBL/DDBJ database.
Twenty-five genes were up-regulated and seven were downregulated as shown in Tables 3 and 4 . Nine of the 32 genes (Upp, Gcsfr, Mpo, Cd53, Cpa3, S100a9, Gzmb, Pim2 and interferon-inducible protein) had been identified previously as being under the downstream control of AML1-MTG8.
39,40
Leukemia Interestingly, several intracellular granule protein genes were up-regulated in AML1-MTG8-expressing cells. Ctsg and Mpo were 26.6-, and 6.3-fold up-regulated in the presence of AML1-MTG8, respectively. Their gene products, cathepsin G and myeloperoxidase, are major constituents of the matrix of azurophil (or primary) granules, which are normally produced at the promyelocyte stage of neutrophil maturation. 43 The Lcn2 gene was up-regulated, 21.1-fold. Its product, NGAL, is normally contained in specific (or secondary) granules 44 formed during the myelocyte to metamyelocyte stages. 43 The lyzs gene, whose product, lysozyme, is present in azurophil and specific granules as well as in gelatinase (or tertiary) granules, 45 was 5.2-fold up-regulated. Furthermore, the Gcsfr, C3, S100a8 and S100a9 genes, which are known to be upregulated during maturation of myeloid cells, [46] [47] [48] were also up-regulated by AML1-MTG8. These results indicated that the L-G cells expressing AML1-MTG8 display a more differentiated phenotype than control L-G cells at the molecular level, although no apparent morphological differences between both the cells cultured in the presence of IL-3 were observed (data not shown). In addition, the Prtn3 and Cd68 genes which encode azurophil granule proteins, proteinase 3 and CD68, was also 2.8-and 2.7-fold up-regulated, respectively, although other genes encoding azurophil granule proteins (neutrophil elastase, CD63, ␣1-antitrypsin, ␣-mannosidase, ␤-glucoronidase, and N-acetyl-␤-glucosaminidase) were not affected in microarray analysis (Figure 1 ). It should also be noted that genes encoding the constituents of specific and gelatinase granules and secretory vesicles were not affected by AML1-MTG8, except for Lcn2 and Lyzs (Figure 1 ).
Figure 1
The up-regulation of genes encoding neutrophil granule proteins determined by the use of oligonucleotide microarrays. Bars indicate fold induction in gene expression averaged from two independent experiments. Black bars indicate induction judged to be significant by the three-fold change criteria (see text). Hatched bars indicate induction to be more than two-fold. The localization of the gene products is also shown. (+) means that these proteins exist in a part of specific granules (see also Figure 6 ). The genes encoding cathepsin G, myeloperoxidase, proteinase 3, CD68, lysozyme, and NGAL were up-regulated by AML1-MTG8. The genes encoding the constituents of specific and gelatinase granules and secretory vesicles were not significantly affected by AML1-MTG8, except for genes encoding lysozyme and NGAL.
Confirmation by Northern hybridization analysis
To confirm the results obtained from the oligonucleotide microarray analysis, we performed Northern hybridization for 19 of the 32 genes that we identified. For all of the 19 genes, there was good correlation between the results of these two experiments (Tables 3 and 4 , and Figure 2) . Significantly, the increased expression of all of the neutrophilic differentiationassociated genes was confirmed. Furthermore, Northern hybridization demonstrated that the Ela2 gene, encoding neutrophil elastase, was also up-regulated by AML1-MTG8 (Figure 2 ). This gene was not identified by the microarray analysis probably because of its low level of expression. Neutrophil elastase is one of the major neutral proteases of azurophil granules along with cathepsin G and proteinase 3. Northern analysis also confirmed that AML1-MTG8 did not alter the expression of the genes encoding lactoferrin, gp91phox, and gelatinase B (Figure 2 ).
Induction of granule protein genes in L-G cells cultured in the presence of G-CSF
The up-regulation of genes encoding azurophil granule proteins caused by AML1-MTG8 suggested that AML1-MTG8
Figure 2
Analyses of the expression of candidate genes regulated by AML1-MTG8 by Northern hybridization. Total RNA from control L-G cells and those expressing AML1-MTG8, grown in the presence of IL-3, was analyzed using each cDNA probe. Human G3PDH cDNA was used as a control probe. The Dusp2, Ctsg, Lcn2, Hpn, C3, Mpo, Mcpt8, Cd59a, Lyzs, Emr1, Prtn3 and Ela2 genes were up-regulated by AML1-MTG8. In contrast, the expression of the Ltf, Cybb and Mmp9 genes was not significantly altered.
Leukemia might induce differentiation of L-G cells into promyelocytes, because azurophil granules are formed at the promyelocyte stage. Thus, it was important to confirm that the expression of these genes was actually affected during the differentiation of L-G cells induced by G-CSF and to analyze how they were regulated by AML1-MTG8 in the presence of G-CSF. We therefore performed Northern analysis using RNA prepared from control L-G cells and those expressing AML1-MTG8 cultured for 0 to 5 days in the presence of G-CSF. In control cells induced to differentiate by G-CSF, the expression of the Mpo, Prtn3, lyzs and Lcn2 genes was increased compared to their expression in cells grown in the presence of IL3, whereas there was no detectable expression of the Ctsg gene ( Figure  3 ). On the other hand, in the cells expressing AML1-MTG8, the expression of these genes, including Ctsg, was further enhanced during culture in the presence of G-CSF compared to their expression during culture with IL-3 ( Figure 3 ). These results confirmed that AML1-MTG8 has the ability to induce neutrophilic differentiation. In addition, the genes encoding lactoferrin in specific granules and gelatinase B in gelatinase granules were up-regulated in the control cells during differentiation induced by G-CSF, but the expression of these genes was not altered in the cells expressing AML1-MTG8 ( Figure  3 ). This result suggests that AML1-MTG8 inhibits differentiation past the promyelocyte stage.
Reversion of AML1-MTG8-induced up-regulation of granule protein genes by AML1b overexpression
Overexpression of AML1b can completely rescue the effect of AML1-MTG8 on cell proliferation and differentiation of L-G cells in response to G-CSF. 18 To examine whether AML1b overexpression could also reverse the up-regulation of genes encoding early neutrophil granule proteins by AML1-MTG8, we constructed control cells and those expressing AML1b, AML1-MTG8, and both AML1-MTG8 and AML1b, as Human G3PDH cDNA was used as a control probe. described previously. 40 In these cells, the expression of exogenous AML1b protein was more than five-fold higher than that of AML1-MTG8 protein (data not shown; see also Ref. 40) . Northern hybridization analysis showed that the Mpo, Lyzs and Lcn2 genes were down-regulated by AML1b and that the up-regulation of the Mpo, Prtn3, Lyzs and Lcn2 genes caused by AML1-MTG8 were reversed by AML1b overexpression (Figure 4) .
Expression of granule protein genes in leukemic cells carrying t(8;21)
To confirm that our findings in L-G cells reflect the phenomena in leukemic cells, the expression of the MPO (myeloperoxidase), PRTN3 (proteinase 3), LYZ (lysozyme), LCN2 (NGAL), CTSG (cathepsim G), LTF (lactoferrin), and MMP9 (gelatinase B) genes was examined in clinical samples by semiquantitative RT-PCR ( Figure 5 ). We analyzed five control patients (lanes C1 to C5) who were in complete remission from leukemia or not in leukemia (see Materials and methods), two non-t(8;21) AML-M2 patients (lanes P1 and P2), and three t(8;21) AML-M2 patients (lanes P3 to P5). The expression of the AML1-MTG8 chimeric transcript in t(8;21) AML-M2 patients was also confirmed by RT-PCR (top panel). All the granule protein genes that we examined were expressed in control patients. In AML-M2 patients either with or without t(8;21), MPO, PRTN3 and LYZ were commonly expressed but the expression of LTF and MMP9 could not be detected. LCN2 was not expressed in non-t(8;21) AML-M2 patients but
Figure 4
Northern hybridization analyses of control L-G cells and those expressing AML1b, AML1-MTG8, and both AML1-MTG8 and AML1b. L-G cells infected with LXSH or LXSH-HA-AML1-MTG8 were further infected with LNSX or LNSX-HA-AML1b retroviruses. Total RNA from these cells grown in the presence of IL-3 was analyzed using each cDNA probe. Overexpression of AML1b reversed the increased expression of the Mpo, Prtn3, Lyzs and Lcn2 genes in AML1-MTG8-expressing L-G cells. Human G3PDH cDNA was used as a control probe. expressed in the t(8;21) patients. Unexpectedly, CTSG was expressed in non-t(8;21) AML-M2 patients but not in the t(8;21) AML-M2 patients. Except for CTSG, these results were consistent with the finding that AML1-MTG8 up-regulates the genes encoding early myeloid granule proteins in the L-G cells. In addition, the expression levels of MPO, PRTN3 and LYZ, and LCN2 were correlated well with the expression of the AML-MTG8 transcript in t(8;21) AML-M2 patients. Thus, it is likely that AML1-MTG8 contributes to the expression of early myeloid garanule protein genes in t(8;21) leukemic cells.
Discussion
Microarray technology allows the expression profile of thousands of genes to be determined at the same time and provides an unprecedented insight into a cell's overall biological state. In this study, we assessed the expression of approximately 6500 genes using oligonucleotide microarrays and identified 32 candidate genes under the downstream control of AML1-MTG8 by comparing gene expression profiles between control L-G cells and those expressing the AML1-MTG8 fusion gene. We previously used a differential display method in the same cell system and identified 24 genes under the downstream control of AML1-MTG8. 39 Eleven of these 24 genes were included in the 6500 genes on the microarrays, and seven of the 11 genes were re-identified by microarray analyses. The expression of three of the remaining four genes, Tis11b, Elanh2 (monocyte/neutrophil elastase inhibitor) and Siat1 (sialyltransferase 1), was found to be altered in the microarray analyses (2.7-, 2.4-, and 2.9-fold changed, respectively) (data not shown), although they were excluded by the three-fold change criteria. These results demonstrate that microarray technology is a powerful and practical tool for exploring gene expression on a large scale. Of the 32 candidate genes identified as being under the downstream control of AML1-MTG8, we have previously identified seven and Shimizu et al 40 identified two, Mpo and Gcsfr. The other 23 genes have not been reported to be affected by AML1-MTG8.
Expression profiling with microarrays revealed the alterations of cell function caused by AML1-MTG8. One of the most notable results in this study was that AML1-MTG8 upregulated many genes associated with neutrophilic differentiation. The expression of the Gcsfr, C3, S100a8 and S100a9 genes, which are known to be up-regulated during maturation of neutrophils, [46] [47] [48] was enhanced by AML1-MTG8. In addition to these genes, many granule protein genes such as Ctsg, Lcn2, Mpo, Lyzs, Prtn3 and Ela2 were also up-regulated. The most primitive myeloblasts have no intracellular granules, and during subsequent differentiation, different types of neutrophil granules are formed. 43, 49 The earliest granules formed are azurophil granules at the promyelocyte stage. Then, from the myelocyte to the segmented cell stage, specific granules, gelatinase granules and secretory vesicles are formed sequentially (see Figure 6 ). Cathepsin G, myeloperoxidase, proteinase 3, neutrophil elastase, and lysozyme encoded by Ctsg, Mpo, Prtn3, Ela2 and Lyzs, respectively, are azurophil granule proteins, 43 although lysozyme is also present in specific and gelatinase granules. 45 NGAL encoded by Lcn2 is normally present in specific granules. 44 Expression of the genes encoding specific and gelatinase granule proteins other than lysozyme and NGAL were not affected by AML1-MTG8 (Figure 1 ). These results indicate that the L-G cells expressing AML1-MTG8 are more differentiated than the control cells, but probably cannot differentiate past the promyelocyte to myelocyte stages. It thus
Figure 5
Semiquantitative RT-PCR analyses of the expression of neutrophil granule protein genes in controls (C1 to C5) and AML-M2 patients without t(8;21) (P1 and P2) and with t(8;21) (P3 to P5). ACTB (␤-actin) transcript was amplified as a control.
Figure 6
Constituents of different neutrophil granules formed during maturation of neutrophils. Genes up-regulated by AML1-MTG8 are described in the shaded boxes and unaffected genes are described in the open boxes. AML1-MTG8 partially induces the genes encoding azurophil granule proteins in the absence of G-CSF and blocks the induction of genes encoding specific and gelatinase granule and secretory vesicle proteins in response to G-CSF.
appears that ectopic expression of AML1-MTG8 induces the myeloid cell differentiation of L-G cells even in the absence of the differentiation signal of G-CSF, as illustrated in Figure  6 . On the other hand, after addition of G-CSF to the cells expressing AML1-MTG8, there was no increase in the expression of the genes encoding lactoferrin in specific granules and gelatinase B in gelatinase granules, whereas in the control L-G cells, gradual increases in the expression of these genes occurred. It is likely that AML1-MTG8 blocks the G-CSF-induced up-regulation of the genes encoding peroxidenegative granule constituents ( Figure 6 ). In contrast, the expression of the azurophil granule genes, Ctsg, Mpo, Prtn3 and Lyzs, was increased in the cells expressing AML1-MTG8, in response to G-CSF. These results correlate well with the pathological characteristics of t(8;21) leukemia, such as the presence of mature but morphologically aberrant myeloid cells marked by intense azurophil granulation and the absence of specific granules. 5 In addition, we also showed that the expression of MPO, PRTN3 and LYZ, and LCN2 in t(8;21) AML-M2 patients was relevant to their AML-MTG8 transcript level ( Figure 5 ). AML1-MTG8 itself may determine the cell lineage of leukemic cells with the t(8;21) translocation, and play a crucial role in defining the characteristic abnormal features associated with maturation of these cells. In L-G cells, AML1-MTG8 also up-regulated the macrophagespecific gene, Emr1, and the mast cell-specific genes, Mcpt8 and Cpa3, which suggests that AML1-MTG8 might control cell differentiation not only for the myeloid lineage but also for other lineages such as those that produce macrophages and mast cells. However, the genes encoding the B cell antigen CD19 and the NK cell antigen CD56, which are often expressed in t(8;21) leukemic cells, 50 were not up-regulated by AML1-MTG8 in L-G cells (data not shown).
AML1-MTG8 also affected several genes associated with extracellular signal transduction pathways. The genes encoding the cell surface receptors, Gcsfr, Cd53 and Emr1, were up-regulated. In cells expressing AML1-MTG8, increased numbers of receptors may provoke an abnormal response to the presence of specific ligands. Gcsfr, which encodes the G-CSF receptor, was shown to be an important downstream gene involved in the G-CSF-dependent cell proliferation of AML1-MTG8-expressing L-G cells. 40 Another gene, Dusp2, which encodes a protein phosphatase associated with extracellular signal-regulated kinase (ERK), was identified as the most strongly up-regulated gene among those identified in this study. Constitutive Dusp2 expression was shown to specifically inhibit ERK activity, which is normally stimulated by mitogen. 51 It is possible that AML1-MTG8 modulates phosphorylation and dephosphorylation of signal transducers to affect cell growth and differentiation.
Several genes that were reported to play an important role in proliferation and metastasis of solid tumors were also affected by AML1-MTG8. These genes encoded ornithine decarboxylase, hepsin and arachidonate 12-lipoxiganase. Ornithine decarboxylase, encoded by Odc, is a key regulatory enzyme involved in the biosynthesis of polyamines. Previous studies showed that ornithine decarboxylase was highly up-regulated in proliferating and transformed cells, 52, 53 and that overexpression of ornithine decarboxylase in NIH 3T3 cells induced malignant transformation characterized by the ability of the cells to form colonies in semi-solid medium and to form rapidly progressing tumors in nude mice. [53] [54] [55] Hepsin, encoded by Hpn, is a type-II membrane-associated serine protease, 56 and is frequently overexpressed in several tumor cell lines, including hepatoma, mammary carcinoma, epithelioid carcinoma, and ovarian carcinomas. [57] [58] [59] An anti-hepsin antibody or hepsin-specific antisense oligonucleotides inhibited the growth of human hepatoma cells, indicating that hepsin was probably essential for their growth. 58 Arachidonate 12-lipoxiganase, encoded by Alox12, is a member of the lipoxygenase family and is expressed in platelets, megakaryocytes, epidermal cells, and some tumor cell lines. [60] [61] [62] [63] Overexpression of arachidonate 12-lipoxiganase in the human breast cancer cell line MCF-7 and the human prostate adenocarcinoma cell line PC3 stimulates tumor growth by inducing angiogenic activity. 64, 65 At present, we have not determined if the expression of these genes is affected in leukemic cells. However, if the aberrant expression of these genes is observed in leukemia cells carrying the t(8;21) translocation, then it might explain the predisposition to extramedullary tumor formation of t(8;21) leukemia.
In this paper, we found that many genes associated with neutrophilic differentiation were up-regulated by the AML1-MTG8 expression. This up-regulation was reversed by AML1b overexpression (Figure 4 ), indicating that AML1-MTG8 worked on these genes by modulating the AML1b function. However, the underlying mechanism that results in changes of the expression of these genes still remains to be determined. One possible explanation is that AML1-MTG8 enhances the expression of another transcription factor gene(s) involved in granulocytic differentiation. For instance, PU.1 is known to be an important transcription factor associated with myeloid differentiation. Its DNA binding sequence exists almost ubiquitously in the promoters of myeloid-specific genes and has been shown to be functional in the promoters of Mpo, Ctsg, Ela2, Prtn3, Lyzs and Gcsfr. 19, [66] [67] [68] [69] [70] [71] As well, C/EBP␣, Myb, Sp1, and Oct-1 are known to be involved in normal myeloid differentiation. 72 However, the microarray analysis showed that AML1-MTG8 did not enhance the expression of these genes in L-G cells (data not shown), and moreover, a recent report 73 showed that AML1-MTG8 down-regulates C/EBP␣ in t(8;21) AML. AML1-MTG8 might regulate the expression of genes encoding unknown factors that modify the function of these transcription factors. Shimizu et al, 40 using the same L-G cell system, recently demonstrated that AML1-MTG8 enhances the expression of Cebpe, which encodes a transcription factor C/EBP⑀ and that the overexpression of C/EBP⑀ induces the up-regulation of Mpo and Gcsfr. C/EBP⑀ may contribute to the AML1-MTG8-mediated induction of granulocytic differentiation, although it is still unknown whether this gene is regulated by AML1-MTG8 directly or indirectly. The second explanation is that AML1-MTG8 directly up-regulates differentiation-associated genes by binding to AML1-binding sites. Mpo and Ela2 have been shown to be directly transactivated by AML1. 19 Furthermore, Ctsg, Lyzs and Lcn2 contain the consensus AML1-binding motif TGT/cGGT within their promoter sequences, suggesting that these genes are also direct targets for AML1. Generally, it is accepted that AML1-MTG8 dominantly represses AML1-dependent transcriptional activation. However, AML1-MTG8 appears to have other actions: AML1-MTG8 up-regulates the M-CSF receptor gene synergistically with AML1, 74 but upregulates the BCL-2 gene independently of AML1 through an AML1-binding site located in the promoter sequence of the BCL-2 gene. 75 Thus, in our L-G cell system, AML1-MTG8 might enhance the expression of the genes involved in granulocytic differentiation by similar mechanisms. The other explanation is that the effect of AML1-MTG8 on cell proliferation may result in the differentiated phenotypes. Recently, it was reported that inhibition of AML1 activity in mouse Ba/F3 B-883 lymphoid cells retards cell proliferation by down-regulating the Cdk4 gene, 76 and induced expression of AML1-MTG8 in human U937 leukemia cells cause growth arrest with decreased expression of CDK4, MYC and BCL2. 77 L-G cells expressing AML1-MTG8 also show slight growth retardation in the presence of IL-3, 38 although with the microarray analysis we could not find any alteration in expression of Cdk4, Myc and Bcl2 (data not shown). This growth retardation may lead to the up-regulation of differentiation-associated genes, because enhanced growth signal usually inhibits differentiation.
The expression of early myeloid-specific genes in AML1-MTG8-expressing L-G cells was further enhanced during culture in the presence of G-CSF. This result appears to be inconsistent with the finding by Lou et al, 76 that inhibition of AML1 function by KRAB-AML1-ER in mouse 32Dcl3 myeloid cells prevents Mpo induction in response to G-CSF. This may result from the different cell lines used. Otherwise, the upregulation of early myeloid-specific genes may require some AML1-MTG8-specific modulation of AML1 function but not its inhibition, because other leukemic fusion proteins to inhibit AML1 function such as CBF␤-SMMHC and TEL-AML1 are not found in AML-M2. Further studies will be necessary to elucidate the precise mechanism of induction of the differentiated phenotypes by AML1-MTG8.
